In
Syngenta Crop Prot., LLC v. Willowood, LLC, No. 2018-1614;
-2044 (Fed. Cir. Dec. 18, 2019), the Federal Circuit vacated
the district court's non-infringement judgment regarding a
claimed process and remanded for further proceedings. The Court
held that infringement under 35 U.S.C. § 271(g), which
prohibits importing, offering to sell, selling, or using within the
US a product made by a process patented in the US, does not require
a single entity to perform all of the steps of a patented
process.
Syngenta sued several Willowood entities for patent and
copyright infringement relating to Willowood's azoxystrobin
pesticide. Certain asserted claims were directed to methods for
producing the pesticide. Denying Syngenta's motion for summary
judgment of infringement, the district court interpreted section
271(g) to require that all steps of a patented process be performed
by or at the direction or control of a single entity before
liability arises.